Latest filing published 07 Jun 2024 for Kalaris Therapeutics, Inc..
Insider track record
No signal scores available.
Derek N. Adams: trading record in brief
Derek N. Adams discloses dealings in Kalaris Therapeutics, Inc. to SEC (Form 4). Between 11 May 2023 and 6 June 2024, the trades on record add up to 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 7 June 2024 with a share grant in Kalaris Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Derek N. Adams
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,000 shares0Common StockSEC:0000950170-24-070601:0
- 35,000 shares0Common StockSEC:0001209191-23-029100:0
2 of 2 declarations
